text.skipToContent text.skipToNavigation
You searched for "cord/cd31.are"
Too many choices? Use the filter option on the left to narrow your product listing.
71-80 of 702 results
1-10 of 177 results
  • The Compendia are ready. Are you?
    Explore the new regulatory landscape for rFC and MAT as the assays gain global approval. rFC and MAT are no longer the 'alternatives'.
    Watch Video
  • Generation of hiPSCs from Cord Blood Cells With the 4D-Nucleofector® System
    A scientific paper by Lonza, outlining the generation of iPSCs from Cord Blood Cells using the 4D-Nucleofector® System
  • Webinar - Hepatocytes in the drug development pipeline
    Overview of how primary hepatocytes are used in drug development
  • Advancing Bone Disease Research – Dissociated Rat Calvariae Osteoblasts Display Optimal Mineralization and Are Easily Transfected Using Nucleofection
    The data provided in this white paper show the quality and sensitivity of cryopreserved dissociated rat calvariae osteoblasts for in vitro studies. Furthermore, application of the 4D-Nucleofector™ System for efficient transfection of dissociated osteoblasts represents a significant advantage for investigating bone biology.
  • Hematopoietic and Immune Cell Products - Essential Tools for Hematopoietic Research
    Lonza_Brochures_Hematopoietic_and_Immune_Cell_Products_-_Essential_Tools_for_Hematopoietic_Research.pdf
  • PYROSTAR™ ES-F Series Brochure
    The PYROSTAR™ ES-F series of reagents are endotoxin-specific and unreactive to β-D-Glucan
  • Confidence for adopting the rFC method in your lab
    Fact-based reference materials for those companies who are considering adopting the rFC method in their labs.
  • Troubleshooting Guide - PYROGENT® Gel Clot LAL Assay
    Most problems encountered in the use of the PYROGENT® Gel Clot Limulus Amebocyte Lysate (LAL) Assay fall into two basic categories - no firm gels are observed in reaction tubes where firm gels are expected or firm gels form in reaction tubes, which are expected to yield negative results. This Tech Tip takes a deeper look into each of these categories and provides troubleshooting guidance.
  • Expanded HUVECs for High-throughput Screening
    HUVECs are a good primary endothelial cell type for many in vitro studies and also for several high-throughput screening applications. Consequently, Lonza offers, HUVEC-XL. These cells are expanded to passage-3 from pooled P1-HUVECs and packaged at 10 million cells per ampoule.
  • NPCs Hepatic Non-Parenchymal Cells
    These additional liver cell types provide a complete building set supporting complex cell culture modeling. Applications include developing more physiologically relevant in vitro models for complex liver diseases and toxicity testing of new drugs and chemicals.